Agape ATP Corporation (ATPC) Cash Flow Statement
Where ATPC’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- −$2.4M
- Capital expenditures
- $1,049 0.1% of revenue
- Free cash flow
- −$2.4M −158.4% margin
- Returned to shareholders
- —
- Change in cash
- −$1.9M cash at year-end $140,072
Cash from operations
−$2.4M
Investments (net)
−$23.0M
Net borrowing (repayment)
−$22,685
Shares issued
+$23.0M
Other financing
+$521,331
Currency & other
+$14,605
Change in cash
−$1.9M
Drawn to scale: where the cash came from and how it was used. Hover for values.
ATPC operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
ATPC cash flow trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$100,2622016 | −$2.4M2025 | — | |
| Capital expenditures | $02016 | $1,0492025 | — | |
| Free cash flow | −$100,2622016 | −$2.4M2025 | — | |
| Free cash flow margin | −71.5%2017 | −158.4%2025 | −87.0 pts | |
| Share buybacks (net) | $02022 | $02024 | — | |
| Capex / revenue | 0.0%2017 | 0.1%2025 | +0.1 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ATPC cash flow by activity
OperatingInvestingFinancingChange in cash
ATPC net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
ATPC cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$2.3M | −$2.5M | −$2.1M | −$1.7M | −$2.5M | $354,766 | −$677,862 | −$130,274 | −$130,274 | −$75,362 |
| Depreciation & amortization | $227,978 | $226,652 | $223,194 | $217,940 | $217,209 | $163,473 | $161,968 | — | — | — |
| Stock-based compensation | — | — | −$456,823 | — | — | — | — | — | — | — |
| Change in working capital | −$38,436 | −$577,735 | −$139,571 | $572,381 | $807,455 | −$744,320 | $156,595 | −$247,858 | −$247,858 | −$24,900 |
| Other non-cash items | −$295,357 | $110,912 | $481,312 | $64,075 | $654,174 | −$331,870 | $245,354 | $30,155 | $30,155 | $0 |
| Cash from operating activities | −$2.4M | −$2.7M | −$2.0M | −$811,683 | −$845,842 | −$557,951 | −$113,945 | −$347,977 | −$347,977 | −$100,262 |
| Investing activities | ||||||||||
| Capital expenditures | −$1,049 | −$50,162 | −$52,320 | −$32,119 | −$3,959 | −$4,912 | −$4,734 | $0 | $0 | $0 |
| Investments (net) | −$23.0M | −$50,050 | −$33,542 | −$32,119 | −$3,959 | $1.3M | −$1,500 | — | — | — |
| Acquisitions & other investing | $0 | $50,162 | $68,611 | $32,119 | $3,959 | $4,912 | $4,734 | −$1.4M | −$1.4M | — |
| Cash from investing activities | −$23.0M | −$50,050 | −$17,251 | −$32,119 | −$3,959 | $1.3M | −$1,500 | −$1.4M | −$1.4M | — |
| Financing activities | ||||||||||
| Share repurchases & issuance (net) | — | $0 | −$93,889 | $0 | — | — | — | — | — | — |
| Net borrowing (repayment) | −$22,685 | −$11,856 | −$9,594 | $0 | — | — | −$5,318 | — | — | — |
| Shares issued | $23.0M | $0 | $5.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | $521,331 | $0 | $0 | −$234,466 | −$19,061 | −$22,091 | $745 | $2.9M | $2.9M | $2.4M |
| Cash from financing activities | $23.5M | −$11,856 | $5.4M | −$234,466 | −$19,061 | −$22,091 | −$4,573 | $2.9M | $2.9M | $2.4M |
| Summary | ||||||||||
| Net change in cash | −$1.9M | −$2.8M | $3.4M | −$1.2M | −$919,752 | $773,143 | −$3.3M | $1.2M | $1.2M | $2.3M |
| Cash at end of period | $140,072 | $2.0M | $4.8M | $1.4M | $2.6M | $3.5M | $238,937 | $3.5M | $3.5M | $2.3M |
| Free cash flow | −$2.4M | −$2.8M | −$2.1M | −$843,802 | −$849,801 | −$562,863 | −$113,945 | −$347,977 | −$347,977 | −$100,262 |
| Free cash flow margin | −158.4% | −209.9% | −143.5% | −45.4% | −83.6% | −16.3% | −13.3% | −22.5% | −71.5% | — |
| Capex / revenue | 0.1% | 3.8% | 3.7% | 1.7% | 0.4% | 0.1% | 0.6% | 0.0% | 0.0% | — |
| Operating cash flow / net income | — | — | — | — | — | −1.57 | — | — | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | $116,809 | −$340,906 | −$376,937 | −$595,370 | −$623,246 | −$712,919 | −$826,595 | −$524,039 | −$432,316 | −$703,094 | −$974,430 | −$324,735 |
| Depreciation & amortization | $32,828 | $48,100 | $56,646 | $76,071 | $44,236 | $51,025 | $68,487 | $63,973 | $47,406 | $46,786 | $49,966 | $55,631 |
| Stock-based compensation | — | — | — | — | — | — | — | — | — | — | −$90,457 | — |
| Change in working capital | $433,392 | $203,170 | $421,337 | $277,447 | $81,547 | −$818,767 | $36,969 | $31,235 | −$55,492 | −$590,447 | −$120,271 | $11,583 |
| Other non-cash items | −$693,347 | −$305,134 | −$309,394 | −$14,890 | $3,005 | $26,787 | $75,804 | $3,951 | $27,862 | $3,295 | $242,986 | $3,990 |
| Cash from operating activities | −$110,318 | −$394,770 | −$208,348 | −$256,742 | −$494,458 | −$1.5M | −$645,335 | −$424,880 | −$412,540 | −$1.2M | −$892,206 | −$253,531 |
| Investing activities | ||||||||||||
| Capital expenditures | $0 | −$382 | −$382 | −$7 | −$11 | −$649 | −$1,440 | −$45,155 | −$3,567 | −$45,124 | −$45,124 | −$701 |
| Investments (net) | $0 | $0 | $0 | −$7 | −$11 | −$23.0M | −$1,439 | −$45,044 | −$3,567 | $0 | −$10,051 | −$701 |
| Acquisitions & other investing | $144 | $0 | — | $7 | $11 | $649 | $1,440 | $45,155 | $3,567 | $35,073 | $45,124 | $701 |
| Cash from investing activities | $144 | −$382 | — | −$7 | −$11 | −$23.0M | −$1,439 | −$45,044 | −$3,567 | −$10,051 | −$10,051 | −$701 |
| Financing activities | ||||||||||||
| Share repurchases & issuance (net) | — | — | — | — | — | — | — | — | — | −$93,889 | −$93,889 | — |
| Net borrowing (repayment) | −$949 | −$6,350 | −$5,975 | −$5,755 | −$5,613 | −$5,342 | −$5,165 | −$3,844 | — | — | — | — |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $23.0M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$81,480 | $502,824 | $207,612 | $187,086 | $126,633 | $0 | $0 | $0 | −$1,948 | $92,990 | $5.5M | −$91,050 |
| Cash from financing activities | −$82,429 | $496,474 | $201,637 | $181,331 | $121,020 | $23.0M | −$5,165 | −$3,844 | −$1,948 | −$899 | $5.4M | −$91,050 |
| Summary | ||||||||||||
| Net change in cash | −$170,091 | $80,707 | $6,358 | −$82,259 | −$362,821 | −$1.5M | −$678,790 | −$441,951 | −$419,542 | −$1.3M | $198,360 | −$342,095 |
| Cash at end of period | $50,688 | $220,779 | $140,072 | $133,714 | $215,973 | $578,794 | $2.0M | $2.7M | $3.2M | $3.6M | $510,019 | $311,659 |
| Free cash flow | −$110,318 | −$394,770 | −$208,730 | −$256,749 | −$494,469 | −$1.5M | −$646,775 | −$470,035 | −$416,107 | −$1.2M | −$937,330 | −$254,232 |
| Free cash flow margin | −805.7% | −144.3% | −52.3% | −69.3% | −106.2% | −503.2% | −179.8% | −141.9% | −132.9% | −390.2% | −239.7% | −71.6% |
| Capex / revenue | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.2% | 0.4% | 13.6% | 1.1% | 14.2% | 11.5% | 0.2% |
| Operating cash flow / net income | −0.94 | — | — | — | — | — | — | — | — | — | — | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
ATPC cash generation
In fiscal 2025 (ended December 31, 2025), Agape ATP generated -$2.4 million of cash from operations and spent $0.0 million on capital expenditures, leaving free cash flow of -$2.4 million, −158.4% of revenue. Cash and equivalents fell by $1.9 million over the year.
Related: ATPC income statement, ATPC balance sheet. See the ATPC stock overview for the latest quote and news.
ATPC cash flow FAQ
What is Agape ATP's free cash flow?
Agape ATP's free cash flow was -$2.4 million in fiscal 2025: -$2.4 million of operating cash flow minus $0.0 million of capital expenditures It was -$2.8 million a year earlier..
How much cash does Agape ATP generate from operations?
Agape ATP generated -$2.4 million of cash from operating activities in fiscal 2025.
How much does Agape ATP spend on capital expenditures?
Agape ATP spent $0.0 million on capital expenditures in fiscal 2025, 0.1% of revenue, compared with $0.1 million the year before.